IL103462A0 - Preparation of recombinant borrelia proteins - Google Patents
Preparation of recombinant borrelia proteinsInfo
- Publication number
- IL103462A0 IL103462A0 IL103462A IL10346292A IL103462A0 IL 103462 A0 IL103462 A0 IL 103462A0 IL 103462 A IL103462 A IL 103462A IL 10346292 A IL10346292 A IL 10346292A IL 103462 A0 IL103462 A0 IL 103462A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- borrelia proteins
- recombinant borrelia
- recombinant
- proteins
- Prior art date
Links
- 241000589968 Borrelia Species 0.000 title 1
- 208000016604 Lyme disease Diseases 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77904891A | 1991-10-18 | 1991-10-18 | |
| US88876592A | 1992-05-27 | 1992-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL103462A0 true IL103462A0 (en) | 1993-03-15 |
Family
ID=27119531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103462A IL103462A0 (en) | 1991-10-18 | 1992-10-18 | Preparation of recombinant borrelia proteins |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0620860A4 (xx) |
| JP (1) | JPH06511154A (xx) |
| AU (1) | AU676140B2 (xx) |
| CA (1) | CA2121121C (xx) |
| FI (1) | FI941749A (xx) |
| IL (1) | IL103462A0 (xx) |
| NO (1) | NO310417B1 (xx) |
| PT (1) | PT100980B (xx) |
| WO (1) | WO1993008299A1 (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| DE69229476T2 (de) * | 1991-08-15 | 2000-03-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe |
| US6676942B1 (en) | 1991-08-15 | 2004-01-13 | Smithkline Beecham Biologicals (S.A.) | Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
| CA2105629A1 (en) * | 1992-09-14 | 1994-03-15 | Robert S. Becker | Potentiation of immunogenic response |
| US6248562B1 (en) | 1993-11-01 | 2001-06-19 | Research Foundation State University Of New York | Chimeric proteins comprising borrelia polypeptides and uses therefor |
| US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| US6610838B1 (en) | 1997-09-10 | 2003-08-26 | Symbicom Aktiebolag | P13 antigens from Borrelia |
| US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
| GB9811219D0 (en) * | 1998-05-26 | 1998-07-22 | Smithkline Beecham Biolog | Novel process |
| AU4654500A (en) * | 1999-04-21 | 2000-11-02 | Boston Medical Center Corporation | Prevention, diagnosis and treatment of lyme disease |
| DE60131982T2 (de) | 2000-08-18 | 2008-12-11 | Brookhaven Science Associates Llc | Veränderte borrelia burgdorferi ospa |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
| DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| WO1991009870A1 (de) * | 1989-12-22 | 1991-07-11 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff |
| CA2057536C (en) * | 1990-12-21 | 1999-10-26 | John J. Dunn | Cloning and expression of borrelia lipoproteins |
| DE69229476T2 (de) * | 1991-08-15 | 2000-03-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe |
-
1992
- 1992-10-16 WO PCT/US1992/008697 patent/WO1993008299A1/en not_active Application Discontinuation
- 1992-10-16 EP EP92922390A patent/EP0620860A4/en not_active Withdrawn
- 1992-10-16 CA CA002121121A patent/CA2121121C/en not_active Expired - Fee Related
- 1992-10-16 AU AU28011/92A patent/AU676140B2/en not_active Ceased
- 1992-10-16 JP JP5507751A patent/JPH06511154A/ja active Pending
- 1992-10-16 PT PT100980A patent/PT100980B/pt not_active IP Right Cessation
- 1992-10-18 IL IL103462A patent/IL103462A0/xx unknown
-
1994
- 1994-04-15 NO NO19941376A patent/NO310417B1/no not_active IP Right Cessation
- 1994-04-15 FI FI941749A patent/FI941749A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06511154A (ja) | 1994-12-15 |
| NO941376L (no) | 1994-06-17 |
| NO941376D0 (no) | 1994-04-15 |
| WO1993008299A1 (en) | 1993-04-29 |
| EP0620860A4 (en) | 1997-05-02 |
| AU2801192A (en) | 1993-05-21 |
| CA2121121A1 (en) | 1993-04-29 |
| EP0620860A1 (en) | 1994-10-26 |
| AU676140B2 (en) | 1997-03-06 |
| FI941749A (fi) | 1994-05-25 |
| FI941749A0 (fi) | 1994-04-15 |
| PT100980A (pt) | 1994-01-31 |
| CA2121121C (en) | 2003-06-10 |
| NO310417B1 (no) | 2001-07-02 |
| PT100980B (pt) | 1999-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5283793A (en) | Recombinant specific binding protein | |
| HU9400201D0 (en) | Recombinant antibodies for human therapy | |
| GB9112553D0 (en) | Fusion proteins | |
| HUT58371A (en) | Recombinant virus of marek-disease | |
| AU6428890A (en) | Therapeutic peptides and proteins | |
| IL103462A0 (en) | Preparation of recombinant borrelia proteins | |
| ZA895460B (en) | Novel proteins | |
| YU219289A (en) | Recombinant hybride proteins of interleucine-2 | |
| GB9104596D0 (en) | Production of recombinant proteins | |
| IL96688A0 (en) | Expression of delta-endotoxin proteins | |
| ZA928032B (en) | Preparation of recombinant borrelia proteins. | |
| ZA901695B (en) | Recombinant protein receptor | |
| CS56992A3 (en) | Analogs of peptides | |
| GB9312281D0 (en) | Selective resolution of recombinant proteins | |
| IL95064A0 (en) | Molecular cloning of tnf binding protein | |
| GB9025320D0 (en) | N-terminal modification of proteins | |
| GB8828726D0 (en) | Purification of recombinant protein | |
| GB9204180D0 (en) | Purification of recombinant proteins | |
| IL92697A0 (en) | Molecular cloning of tnf binding protein | |
| GB9507442D0 (en) | Recombinant specific binding protein | |
| GB9010740D0 (en) | Peptide compounds and their preparation | |
| GB9127319D0 (en) | Modified proteins | |
| IE881525L (en) | Preparation of protein | |
| GB9116002D0 (en) | Proteins | |
| GB9115999D0 (en) | Proteins |